Curriculum Vitae
Dr. Rohit Kumar
Unit 2, 9354 Esplanade Drive,
Windsor, ON N8R 2A3
tkumar66@bell.net
Phone: 519 300 0801 Fax: 519 300 0888
EXECUTIVE SUMMARY curriculum vitae Dr. R.T. Kumar
Dr. Rohit Kumar is a retired family practitioner and chronic pain physician in Windsor, Ontario.
Dr. Kumar studied Medicine at Dalhousie University in Halifax, Nova Scotia and interned at the Toronto East General and Orthopedic Hospital. He began his residency in Internal Medicine at Dalhousie University, then continued at Oakwood Hospital and Medical Centre in Dearborn, Michigan, where he was a Senior Internal Medicine Resident under the auspices of Wayne University and the University of Michigan.
His appointments have included the Medical Officer for the Canadian Armed Forces Addiction Rehabilitation Clinic, Area Atlantic and a General Duty Medical Officer in the Canadian Forces Hospital in Halifax, N.S. Dr. Kumar has held positions in London at the Regional Cancer Centre and in Windsor at Hotel Dieu-Grace Hospital.
He has received numerous awards and distinctions that consist of grants, studentships, an award of excellence for Coronary Care Unit Supervision, and most valuably, a letter of commendation from the Registrar of the College of Physicians and Surgeons of Ontario as an asset to the profession and for a high level of medical practice standards.
Dr. Kumar has instructed undergraduate and graduate medicine courses; founded and lectured Continuing Medical Education for Nursing Staff; organized, moderated and presented at conferences in Canada, the United States, Europe and Israel, and has authored a medical information column, and over 65 peer-reviewed publication, abstracts and conference presentations.
He has been honoured by Queens University for excellence in teaching nurse practitioners.
Dr. Kumar has also practiced in a teaching position with McMaster University and Health Canada in northern Ontario for Indigenous peoples. Dr. Kumar has been very involved with the communities he has worked in, through committee memberships and other community services.
Dr. Kumar was the first full-time hospitalist in Canada in a team at Hotel Dieu Hospital in Windsor, ON. hospitalist. Dr. Kumar is the
CEO/President of the R.T. Kumar Patient Advocacy Medical Research Corporation which acts acts as a liaison between patients and their physicians, enhancing communication between both parties while leaving medical care with the most responsible physician (MRP). The Corporation also facilitates independent research by Dr. Kumar and other associated partners.
"I have an avid interest in teaching, and this along with a strong research component, as well as an active clinical practice, are an integral part of my future career direction as a primary-care practitioner/clinical researcher. In addition, I also have some formal training and experience in palliative care, chronic pain, and addiction medicine, which have been an integral part of all my clinical experiences."
Dr. Kumar specializes in comprehensive health care for people of all ages. In addition to diagnosing and treating illnesses, family practitioners also put focus on preventative care with routine checkups, tests and personalized coaching on how to maintain a healthy lifestyle. Dr. Kumar possesses immense general knowledge on maintaining health and wellness today. Family practitioners provide more care for the under served and rural populations than any other medical specialty.
He most recently worked as a Disability Adjudicator with the Ministry of Children, Community and Social Services of Ontario. Dr. Kumar has lectured and presented seminars on the judicious use of medical marijuana, having lectured to the Ontario Public Service of Ontario and the Ministry of Children Community of Social Services.
PUBLICATIONS
Schrempf H, Dyson P, Kumar T, Groitl P and Betzler M. Biochemical and genetic analysis of
spontaneous genetic instability in Streptomyces lividans. In: Genetics of Industrial Microorganisms.
1986
Kumar T. DNA amplification and rearrangement associated with tetracycline-sensitive variants of S.
lividans. Presented at the 5th International Symposium on the Genetics of Industrial Microorganisms,
Split, Yugoslavia, 1986 (poster).
Schrempf H, Dyson P, Dittrich W, Kumar T, Betzler M, Habiger C, Bronneke V, Kessler A and Duvel
H. Genetic instability in Streptomyces. In: Biology of Actinomycetes. 1988
Kumar T. Characterization of a 4.4-kb Amplified DNA Sequence from a Tetracycline-sensitive Variant
of Streptomyces Lividans 66. Master's Thesis. Dalhousie University AND University of Munich. 1991
Kovacs MJ, MacKinnon K, Keeney M, Kumar T, Boyle E, Cruckshank M. Assessment of APC
resistance in patients with cancer who develop DVT. Presented at XVth Congress of the International
Society of Thrombosis and Haemostasis, Jerusalem, Israel, June 11-16, 1995 (poster).
Kovacs MJ, MacKinnon K, Keeney M, Wong L, Kumar T, Morrow B and Cruickshank M. Assessment
of APC resistance in patients with cancer patients who develop DVT – An update. American Society of
Hematology Annual Meeting, Seattle Washington, U.S.A., December 1-5, 1995. Published in Blood:
86 (10). Supplement to November 15, 1995 issue.
Kovacs MJ, MacKinnon K, Keeney M, Kumar T, Boyle E, Cruckshank M. Assessment of APC
resistance in patients with cancer who develop DVT. Presented at XVth Congress of the International
Society of Thrombosis and Haemostasis, Jerusalem, Israel, June 11-16, 1995 (poster).
Vincent M, Kocha W, Kumar T, Ballingall D, Tomiak A, Malpage A, Stitt L. Neupogen supported
chemotherapy (CT) in relapsed small cell lung cancer (R-SCLC). Lung Cancer: Strategies for the 21st
Century, Toronto, Canada, September 29-30, 1995.
Kumar T, Greer W and Mandla S. Familial myelodysplastic syndrome in three generations with onset
before age 55. American Society of Hematology Annual Meeting, Seattle, Washington, U.S.A.,
December 1-5, 1995. Published in Blood: 86 (10). Supplement to November 15, 1995 issue.
Kovacs MJ, MacKinnon K, Keeney M, Wong L, Kumar T, Morrow B and Cruickshank M. Assessment
of APC resistance in patients with cancer patients who develop DVT – An update. American Society of
Hematology Annual Meeting, Seattle Washington, U.S.A., December 1-5, 1995. Published in Blood:
86 (10). Supplement to November 15, 1995 issue.
Mandla S, Greer W and Kumar T. Genetic analysis of familial myelodysplastic syndrome: Absence of
linkage to chromosome 5q31. American Society of Hematology Annual Meeting, Seattle, Washington,
U.S.A., December 1-5, 1995. Published in Blood: 86 (10). Supplement to November 15,1995 issue.
Kovacs MJ, MacKinnon K, Keeney M, Kumar T, Boyle E, Cruckshank M. Assessment of APC
resistance in patients with cancer who develop DVT. Presented at XVth Congress of the International
Society of Thrombosis and Haemostasis, Jerusalem, Israel, June 11-16, 1995 (poster).
Mandla S, Goobie S, T Kumar, O Hayne, E Zayed. Analysis of cancer susceptibility genes in a family
with myelodysplastic syndrome. Blood, 1996
Mandla S, Greer W and Kumar T. Genetic analysis of familial melodysplastic syndrome: Absence of
linkage to chromosome 5q31. Submitted to American Society of Hematology Annual Meeting, Seattle,
Washington, U.S.A., December 1-5, 1995 (poster).
Mandla S Goobie S, T Kumar, O Hayne, E Zayed . Analysis of cancer susceptibility genes in a family
with myelodysplastic syndrome. Blood 1996
Mandla S, Goobie S, Kumar R.T., Hayne O, Zayed E, Guernsey
D.L., Greer W. Genetic analysis of familial myelodysplastic syndrome: Absence of linkage to
chromosomes 5q31 and 7q22. Cancer Genetics and Cytogenetics 105:13-118. 1998
Kumar R.T. The Hospitalist Experience in Windsor, ON. (Report on first full time hospitalist
program in Canada). Paper published for seminar held at The Hospitalist Movement in Canada: A
New Strategy for Managing Acute Inpatient Medical Services, Toronto, ON. Dec. 1999
Kumar T, SG Mandla, WL Greer Familial myelodysplastic syndrome with early age of onset. American
journal of hematology, 2000
Kumar T. Medical Marijuana and Palliative Care”. Hospice and Palliative Care Association of Ontario
annual Meeting April 2017
Kumar T. Medical marijuana: Is it really time to lighten. Published online CMAJ July 17, 2017
Kumar. The CMAJ and Medical Marijuana. CMAJ journal online July 24, 2017
Kumar T. Pediatric postoperative analgesia. Published in POEMS CMAJ online October 15, 2017 in
response to: "Oral morphine versus ibuprofen administered at home for postoperative orthopedic pain
in children: a randomized controlled trial" Poonai, et al., 189:E1252-E1258doi:10.1503/cmaj.170017
Kumar T. Gabapentinoids for chronic low back pain: limited evidence, more harm than benefit.
Published in POEMS CMAJ online view and meta-analysis of randomized controlled trials. PLoS Med
2017;14(8):e1002369.
Kumar T. Does the regular use of azithromycin decrease the frequency of exacerbations in adults with
persistent asthma? Published in POEMS CMAJ online October 17, 2017 in response to: Gibson PG,
Yang IA, Upham JW, et al. Effect of azithromycin on asthma exacerbations and quality of life in adults
with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial.
Lancet 2017;390(10095):659-668.
Kumar T. The Cost of Mental Health Care. Canadian Medical Association Journal Online, July 26,
2017
Kumar T. The Hidden Morbidity and Mortality in Mental Health Diagnoses. CMAJ online October 26,
2017
Kumar T. An Update on Medical Marijuana and Palliative Care”. Hospice and Palliative Care
Association of Ontario annual Meeting April
2018
Kumar T. “The Facts about Medical Marijuana”. Ontario Public Service, Scientific Research
Presentations, January 2019
CLINICAL TRIAL SITE
(1) Hot Flash: Use of Gabapentin in the treatment of menopausal hot flash symptoms; study completed
2005
(2) Study comparing Ezetrol and low dose statin with double dose statin.(Merck Frosst); study
completed 2006
(3) Chosen by Hoffman Roche to participate in study of Reminyl in the treatment of early dementia.
(INSPIRE); study completed 2007-2008
(4) C.A.G.E. (COPD care gap evaluation) participant; study completed 2007
(5) EasEE Clik: A patient study of a new insulin pen for Lantus insulin. Study Published by Sanofi
2010
MEDICAL MARINJUANA EXPERTISE - MMJ Publications and Seminars by Dr. Rohit Kumar
Kumar T. Medical Marijuana and Palliative Care”. Hospice and Palliative Care Association (HPCO) of Ontario annual
Meeting April 2017 – 90 minute seminar
Kumar T. Medical marijuana: Is it really time to lighten. Published online CMAJ July 17, 2017
Kumar. The CMAJ and Medical Marijuana. CMAJ journal online July 24, 2017
Kumar T. "Medical Marijuana and Palliative Care Update”. Hospice and Palliative Care Association of Ontario (HPCO) annual Meeting April
2018 - 90 minute seminar
Kumar T. “The Facts about Medical Marijuana”. Ontario Public Service, Scientific Research Presentations, January 2019 -
**** seminar to the entire Ontario Public Service of the government of Ontario in 2018
AWARDS
Masters done with Dr. H. Schrempf who was cited by the Nobel prize committee for her
contribution to the work of the 2008 Nobel Prize Winner in Medicine
1981 Entrance Scholarship Dalhousie University ($1500 CAN)
1985-1987 National Science and Engineering Research Council Grant for Graduate Student
($10,000 CAN)
1987 Summer National Science and Engineering Research Council Summer Studentship ($5000
CAN)
1990 Dalhousie Medical Students Society Silver "D" Medal
1994-1996 National Science and Engineering Research Council Grant for Scientific Research
($20,000 CAN)
1997 Award of Excellence for Coronary Care Unit Supervision, Oakwood Healthcare
System, Oakwood Hospital, Dearborn, MI
****1998 Letter of Commendation from Registrar of College of Physicians and Surgeons of
Ontario on being "... an asset to the medical profession and bringing the art to practice of
medicine...".
****1998-2000 Member of the first full time hospitalist
Team in Canada, Hotel-Dieu Grace Hospital, Windsor, ON
2003 Chosen by the Ontario College of Family Physicians to be an
OpinionLeader/PeerPresenter (for Alzheimer’s Disease for teaching of Family
Physicians in Ontario
2003 Chosen by the College of Physicians and Surgeons of Ontario
Methadone for Pain Working Group to review the College’s draft
Guidelines on the Use of Methadone for Analgesia
2004 Chosen by Hoffman Roche to sit on
Advisory Board for teaching general Practitioners about dementia
2005 Chosen by the Canadian Heart Research Centre to review educational material
on global risk. “Management of global risk: from clinical trials to clinical practice”
2006 Certificate of Achievement from the
Canadian Heart Research Centre for excellence in vascular primary care
2007 Recognition by McMaster University
on excellence of teaching nurse practitioner students
2010 Asked to sit on Advisory Board for Tecta Nyco Med Canada
2019 Top Presentation “The Facts about Medical Marijuana”. Ontario Public Service, Scientific Research
Presentations, January 2019CEO/President of the R.T. Medical Research and Patient Advocacy Corporation